|Bid||0.00 x 0|
|Ask||0.00 x 0|
|Day's Range||72.74 - 73.85|
|52 Week Range||38.43 - 75.45|
|PE Ratio (TTM)||N/A|
|Earnings Date||May 7, 2018 - May 11, 2018|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||64.75|
The last change in the short interest score occurred more than 1 month ago and implies that there has been little change in sentiment among investors who seek to profit from falling equity prices. Over the last month, growth of ETFs holding HAE is favorable, with net inflows of $4.35 billion.
Here take a quick look on three major MedTech companies that are going to make the best out of the recent Tax-Repeal upheaval.
Haemonetics (HAE) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Stock Monitor: Endologix Post Earnings Reporting LONDON, UK / ACCESSWIRE / March 05, 2018 / Active-Investors.com has just released a free earnings report on Haemonetics Corp. (NYSE: HAE ). If you want ...
Haemonetics (HAE) delivers strong plasma revenues, driven by a robust performance in disposables and software in the United States. Also, the market seems upbeat about this new PCS platform.
Companies with favorable efficiency levels are likely to be on investors' radar irrespective of market conditions as price performance is believed to be positively correlated with efficiency
Luminex's (LMNX) extensive product line and rising revenues raise optimism. However, a challenging reimbursement scenario is likely to mar prospects.
The last change in the short interest score occurred more than 1 month ago and implies that there has been little change in sentiment among investors who seek to profit from falling equity prices. Index (PMI) data, output in the Healthcare sector is rising.
NEW YORK, Feb. 12, 2018-- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of Haemonetics ...
NEW YORK, NY / ACCESSWIRE / February 8, 2018 / Roku shares exploded on Wednesday after the company said that a Consumer Report saying the company's smart powered TV could be vulnerable to hacking was wrong ...
The Braintree, Massachusetts-based company said it had a loss of 12 cents per share. Earnings, adjusted for one-time gains and costs, were 62 cents per share. The results exceeded Wall Street expectations. ...
Financial release accessible online BRAINTREE, Mass. , Feb. 6, 2018 /PRNewswire/ -- Haemonetics Corporation (NYSE: HAE) announced that third quarter and year-to-date fiscal 2018 financial results are available ...
BRAINTREE, Mass. , Jan. 25, 2018 /PRNewswire/ -- Haemonetics Corporation (NYSE: HAE) announced the election of Ellen M. Zane to its Board of Directors. Zane is a nationally renowned health care leader ...